C07K 14/70589
Cd45
Official title: {cd45}
C07K14/70589 (Cd45) appears on 28 US grants and 64 published applications in this corpus.
Search patents in C07K- Granted patents
- 28
- Published applications
- 64
- Assignees
- 49
- Inventors
- 138
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 0 |
| 2003 | 2 | 3 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 1 |
| 2010 | 0 | 0 |
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 0 |
| 2015 | 1 | 0 |
| 2016 | 0 | 3 |
| 2017 | 0 | 3 |
| 2018 | 0 | 2 |
| 2019 | 4 | 5 |
| 2020 | 2 | 9 |
| 2021 | 1 | 5 |
| 2022 | 4 | 7 |
| 2023 | 3 | 11 |
| 2024 | 1 | 5 |
| 2025 | 0 | 5 |
| 2026 | 5 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Chimeric antigen receptor for treatment of cancer29 Sep 2026US 12,747,278 B2Industry-Academic Cooperation Foundation, Yonsei University
- Long lived T cells for treating HIV infection4 Aug 2026US 12,698,318 B2Case Western Reserve University
- Anti-MUC1 compositions and methods of use21 Jul 2026US 12,686,726 B2Poseida Therapeutics, Inc.
- Anti-L1CAM antibody or antigen-binding fragment thereof and chimeric antigen receptor comprising same14 Apr 2026US 12,600,776 B2Cartexell Inc.
- Compositions and methods for treating cancer with anti-ROR1 immunotherapy3 Feb 2026US 12,540,179 B2Lentigen Technology, Inc.
- Application of CCR5hi Innate Immune Memory Cells in Preparation of Immunotherapeutic Drug for Treating Sepsis8 Oct 2026US 2026/0306538 A1Children's Hospital of Soochow University
- Tumor memory killer cell and method of producing the same2 Jul 2026US 2026/0183337 A1Dong-A University Research Foundation for Industry-Academy Cooperation
- Molecules and their derivatives directed aganist cd4530 Apr 2026US 2026/0115335 A1Actinium Pharmaceuticals, Inc.
- Compositions and methods for treating a refractory or relapsed cancer or a chronic infectious disease3 Jul 2025US 2025/0213616 A1Institut Curie
- Chimeric antigen receptor tumor infiltrating lymphocytes5 Jun 2025US 2025/0179145 A1H. Lee Moffit Cancer Center and Research Institute, Inc.
Most cited
By later US patents
- Knockout mice62US 5,557,032 AThe Ontario Cancer Institute · 1996
- Product and process for T lymphocyte immunosuppression41US 6,264,950 B1National Jewish Medical and Research Center · 2001
- Knockout mice27US 5,616,491 AThe Ontario Cancer Institute · 1997
- Cell19US 10,172,885 B2UCL Business PLC · 2019
- Chimeric antigen and T cell receptors and methods of use18US 10,603,380 B2Kite Pharma, Inc. · 2020